arrow
王献 封面图

王献 (Xian Wang)

Guizhou Medical University教授
H指数:64
被引数:1.6万

个人简介

"王献 教授 硕士生导师 个人简介:王献,女,教授,硕士研究生导师。主要从事观赏植物种质资源开发应用和室内盆花栽培体系研究工作,在观赏草、紫薇、月季、牡丹以及切花栽培与应..."

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Therapeutic Response to Anti-Vascular Endothelial Growth Factor Retreatment Among Eyes With Stabilized Vision After Being Lost to Follow-Up in Diabetic Macular Edema: A Nationwide, Registry-Based Cohort Study

糖尿病黄斑水肿患者失访后视力稳定,再次接受抗血管内皮生长因子治疗后的治疗反应:一项全国性、基于登记的队列研究

2026-07-010
PRE
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial

新型CDK2/4/6抑制剂culmerciclib (TQB3616) 联合氟维司群治疗HR阳性HER2-negative晚期乳腺癌: 一项随机、双盲、3期临床试验

2025-12-180
OAAI
Sacituzumab Tirumotecan in Participants With Advanced or Metastatic Urothelial Carcinoma and Disease Progression after Chemotherapy and Immune Checkpoint Inhibitors

萨卡图zumab替拉他滨在具有进展期或转移性尿路上皮癌且在化疗和免疫检查点抑制剂治疗后疾病进展的受试者中的应用

2025-11-210
PRE
Exploration of hanging coffin customs and the bo people in China through comparative genomics

通过比较基因组学研究中国悬棺习俗和博人群体

2025-11-200
OAAI
Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers

Beamion BCGC-1:zongertinib治疗晚期HER2阳性乳腺癌或胃肠癌的Ib/II期临床试验

2025-10-170
OAAI
Inhibition of LARP4-mediated quiescence exit of naive CD4+ T cells ameliorates autoimmune and allergic diseases

抑制幼稚CD4 T细胞的LARP4-mediated静止退出可改善自身免疫和过敏性疾病

2025-10-160
PRE
Fluid shear stress activates a targetable mechano-metastatic cascade to promote medulloblastoma metastasis

流体剪切应力激活了一个可靶向的机械性转移级联,以促进髓母细胞瘤转移。

2025-09-020
PRE